Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in acute alcoholic hepatitis
NCT02116556Phase 2Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in alcoholic hepatitis (AH), sponsored by Vall d'Hebron Research Institute. Status: unknown.
02
Drugs
rifaximin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02116556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116556.